HOME >> BIOLOGY >> NEWS
New compound could give some types of cancer the one-two punch

PHILADELPHIA Ohio State University researchers are working on developing a multi-purpose cancer drug that might one day scale back the number of medications some cancer patients need to take.

In laboratory tests, a dual-action compound called OSU 111 has shown promise in killing prostate cancer cells.

"It had a direct toxic effect on cancer cells, and also prevented angiogenesis the formation of new blood vessels from pre-existing ones," said Tom Li, the study's lead investigator and an associate professor of pharmacy at Ohio State.

"It's like using one stone to kill two birds."

Li presented the results on August 22 in Philadelphia at the summer meeting of the American Chemical Society.

OSU 111 is a variation on a theme Li and his colleagues created OSU 111 using a known anti-cancer compound, SU-5416, as a model. Although SU-5416 showed promise in preclinical studies, it did not have the kind of far-reaching effectiveness that researchers had hoped for.

--------------------------------------------------------------------------------

"One drug with dual activity means that the body only has to deal with a single compound, and that could eliminate a lot of complexity in terms of giving medication to patients, the body's ability to absorb a drug and also side effects."

--------------------------------------------------------------------------------

But SU-5416 does provide a good blueprint by which researchers can create dozens of analogs compounds structurally similar, but with slightly different chemical compositions.

"We've made close to 50 different analogs by modifying SU-5416," Li said.

Laboratory experiments show that OSU 111 is one of the most promising analogs for killing cancer cells Li's team has found so far. When treated with OSU 111 in laboratory experiments, the majority of prostate cancer tissue cells died within three days, Li said.

"This compound stopp
'"/>

Contact: Tom Li
li.27@osu.edu
614-688-0253
Ohio State University
22-Aug-2004


Page: 1 2 3

Related biology news :

1. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
2. NJIT chemist speaks Aug. 25 about compound derived from pine tree
3. Scientists identify compounds that mimic calorie restriction
4. Firefly compound lights up protein dance in living animals
5. New compound highly efficacious at reducing human tumour growth
6. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
7. New screening method turns up potential compound for treating anthrax
8. New, non-radioactive screen for antimalarial compounds
9. OHSU team discovers compound that lacks estrogens risks
10. Three molecular-targeted compounds show promise against cancers
11. New compound library to speed drug discovery

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2020)... ... May 06, 2020 , ... The ... become the latest out-of-state company to partner with the device accelerator located ... developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent assays (ELISAs), ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... diseases, announced today that it had been awarded a contract from the Biomedical ... Secretary for Preparedness and Response at the U.S. Department of Health and Human ...
(Date:4/30/2020)... , ... April 28, 2020 , ... ... are Lachman Consultants latest effort in providing timely and critical information to life ... by social distancing and health safety concerns. , “Providing the most up-to-date actionable ...
Breaking Biology News(10 mins):
(Date:5/28/2020)... , ... May 28, 2020 , ... The Security ... security leaders as the 2020 winners of the Women in Biometrics Awards ... IDEMIA , Biometric Update and the SIA Women in Security ...
(Date:5/21/2020)... ... May 19, 2020 , ... Experienced periodontist in Eden ... dental implants and bone grafting through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations ... used to prepare a patient for dental implants, especially when the implants need to ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... cell banks and hMSC bioprocess systems, today announced the launch of its ... extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV product ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a ... Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board ... as work closely with CEO Brian Miller and Sentien’s management team. , ...
Breaking Biology Technology:
Cached News: